CAAS Capital Management’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

CAAS Capital Management’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-43,200	Closed	-$7K	–	1105
2022 Q3	$7K	Hold	43,200	–	–	﹤0.01%	751
2022 Q2	$6K	Hold	43,200	–	–	﹤0.01%	810
2022 Q1	$18K	Hold	43,200	–	–	﹤0.01%	577
2021 Q4	$38K	Hold	43,200	–	–	﹤0.01%	759
2021 Q3	$50K	Sell	43,200 -6,800	-14%	-$7.85K	﹤0.01%	819
2021 Q2	$66K	Hold	50,000	–	–	﹤0.01%	957
2021 Q1	$73K	Hold	50,000	–	–	﹤0.01%	1109
2020 Q4	$125K	Buy	+50,000	New	+$143K	﹤0.01%	785

CAAS Capital Management's LUXAW Position: Q4 2022 in Review

CAAS Capital Management sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 43,200 shares — an estimated $7K sold.

CAAS Capital Management first reported a position in LUXAW in Q4 2020 and held it in 8 quarters. The position peaked at $125K in Q4 2020. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

CAAS Capital Management reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
CAAS Capital Management sold 43,200 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $7K.
CAAS Capital Management first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q4 2020 and held it in 8 quarters.
CAAS Capital Management's Lux Health Tech Acquisition Corp. Warrants position peaked at $125K in Q4 2020.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.